CD55 and neoplasm: As the gold-standard functional CSC assay is limiting dilution tumor initiation in vivo, we injected CD55-silenced and nontargeted control CSCs into immune-compromised mice at 103, 104, and 105 cells/mouse (Fig. 2 D).